111 related articles for article (PubMed ID: 17011457)
1. Effect of downregulation of survivin expression on radiosensitivity of human epidermoid carcinoma cells.
Sah NK; Munshi A; Hobbs M; Carter BZ; Andreeff M; Meyn RE
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):852-9. PubMed ID: 17011457
[TBL] [Abstract][Full Text] [Related]
2. Survivin antisense oligonucleotides effectively radiosensitize colorectal cancer cells in both tissue culture and murine xenograft models.
Rödel F; Frey B; Leitmann W; Capalbo G; Weiss C; Rödel C
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):247-55. PubMed ID: 18406888
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells.
Chao JI; Kuo PC; Hsu TS
J Biol Chem; 2004 May; 279(19):20267-76. PubMed ID: 14988404
[TBL] [Abstract][Full Text] [Related]
4. Antisurvivin oligonucleotides inhibit growth and induce apoptosis in human medullary thyroid carcinoma cells.
Du ZX; Zhang HY; Gao DX; Wang HQ; Li YJ; Liu GL
Exp Mol Med; 2006 Jun; 38(3):230-40. PubMed ID: 16819281
[TBL] [Abstract][Full Text] [Related]
5. Radiosensitization, after a combined treatment of survivin siRNA and irradiation, is correlated with the activation of caspases 3 and 7 in a wt-p53 sarcoma cell line, but not in a mt-p53 sarcoma cell line.
Kappler M; Taubert H; Bartel F; Blümke K; Panian M; Schmidt H; Dunst J; Bache M
Oncol Rep; 2005 Jan; 13(1):167-72. PubMed ID: 15583820
[TBL] [Abstract][Full Text] [Related]
6. Roscovitine sensitizes glioma cells to TRAIL-mediated apoptosis by downregulation of survivin and XIAP.
Kim EH; Kim SU; Shin DY; Choi KS
Oncogene; 2004 Jan; 23(2):446-56. PubMed ID: 14724573
[TBL] [Abstract][Full Text] [Related]
7. Survivin as a therapeutic target for radiation sensitization in lung cancer.
Lu B; Mu Y; Cao C; Zeng F; Schneider S; Tan J; Price J; Chen J; Freeman M; Hallahan DE
Cancer Res; 2004 Apr; 64(8):2840-5. PubMed ID: 15087401
[TBL] [Abstract][Full Text] [Related]
8. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
9. Cell growth inhibition and down-regulation of survivin by silibinin in a laryngeal squamous cell carcinoma cell line.
Bang CI; Paik SY; Sun DI; Joo YH; Kim MS
Ann Otol Rhinol Laryngol; 2008 Oct; 117(10):781-5. PubMed ID: 18998509
[TBL] [Abstract][Full Text] [Related]
10. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.
Ghosh JC; Altieri DC
Clin Cancer Res; 2005 Jun; 11(12):4580-8. PubMed ID: 15958644
[TBL] [Abstract][Full Text] [Related]
11. Centrosome amplification induced by survivin suppression enhances both chromosome instability and radiosensitivity in glioma cells.
Saito T; Hama S; Izumi H; Yamasaki F; Kajiwara Y; Matsuura S; Morishima K; Hidaka T; Shrestha P; Sugiyama K; Kurisu K
Br J Cancer; 2008 Jan; 98(2):345-55. PubMed ID: 18195712
[TBL] [Abstract][Full Text] [Related]
12. Survivin expression is a negative prognostic marker in laryngeal squamous cell carcinoma and is associated with p53 accumulation.
Pizem J; Cör A; Gale N
Histopathology; 2004 Aug; 45(2):180-6. PubMed ID: 15279637
[TBL] [Abstract][Full Text] [Related]
13. Survivin phosphorylation and M-phase promoting factor in oral carcinogenesis.
Pannone G; Bufo P; Serpico R; Rubini C; Zamparese R; Corsi F; Pedicillo MC; Pannone G; Staibano S; De Rosa G; Lo Muzio L
Histol Histopathol; 2007 Nov; 22(11):1241-9. PubMed ID: 17647197
[TBL] [Abstract][Full Text] [Related]
14. Targeting survivin in cancer therapy.
Pennati M; Folini M; Zaffaroni N
Expert Opin Ther Targets; 2008 Apr; 12(4):463-76. PubMed ID: 18348682
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors enhance lexatumumab-induced apoptosis via a p21Cip1-dependent decrease in survivin levels.
Nawrocki ST; Carew JS; Douglas L; Cleveland JL; Humphreys R; Houghton JA
Cancer Res; 2007 Jul; 67(14):6987-94. PubMed ID: 17638911
[TBL] [Abstract][Full Text] [Related]
16. Survivin: a potential prognostic marker and chemoradiotherapeutic target for colorectal cancer.
Xiaoyuan C; Longbang C; Jinghua W; Xiaoxiang G; Huaicheng G; Qun Z; Haizhu S
Ir J Med Sci; 2010 Sep; 179(3):327-35. PubMed ID: 19921309
[TBL] [Abstract][Full Text] [Related]
17. Survivin downregulation by siRNA/cationic liposome complex radiosensitises human hepatoma cells in vitro and in vivo.
Yang W; Sun T; Cao J; Liu F
Int J Radiat Biol; 2010 Jun; 86(6):445-57. PubMed ID: 20470195
[TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides.
Ma X; Wang S; Zhou J; Xing H; Xu G; Wang B; Chen G; Lu YP; Ma D
Oncol Rep; 2005 Jul; 14(1):275-9. PubMed ID: 15944801
[TBL] [Abstract][Full Text] [Related]
19. High survivin expression is associated with favorable outcome in advanced primary oral squamous cell carcinoma after radiation therapy.
Freier K; Pungs S; Sticht C; Flechtenmacher C; Lichter P; Joos S; Hofele C
Int J Cancer; 2007 Feb; 120(4):942-6. PubMed ID: 17187360
[TBL] [Abstract][Full Text] [Related]
20. Apoptotic regulators: P53 and survivin expression in non-small cell lung cancer.
Porebska I; Sobańska E; Kosacka M; Jankowska R
Cancer Genomics Proteomics; 2010; 7(6):331-5. PubMed ID: 21156966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
